Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-02

Clinical Trial Update: NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating NOX1416 for chronic non-healing diabetic foot ulcers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOX1416

Snippet

Sponsor: NOxy Health Products, LLC | Conditions: Diabetic Foot Ulcer | Phase 1 | Status: RECRUITING